Back to BlackRock, Inc. BlackRock, Inc.

RYTMRYTM
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in RHYTHM PHARMACEUTICALS INC

BlackRock, Inc. holds 6.2M shares of RYTM (RHYTHM PHARMACEUTICALS INC), worth $683.6M as of 2026-Q2. The position was decreased (-1.3% shares). RYTM represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$683.6M

Current Shares

6.2M

Total Value Change

+$294.5M

Total Shares Change

-793,813

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
6.2M
-1.3%
$683.6M0.0%$111.03
0
2026-Q1
Decreased
6.2M
-1.0%
$542.4M0.0%$89.56
0
2025-Q4
Decreased
6.3M
-0.1%
$674.1M0.0%$106.76
0
2025-Q3
Increased
6.3M
+0.6%
$636.5M0.0%$100.64
32
2025-Q2
Decreased
6.3M
-8.6%
$396M0.0%$62.73
0
2025-Q1
Decreased
6.9M
-1.4%
$363.1M0.0%$54.80
0
2024-Q4
New
7M
-
$389.1M0.0%$56.34
43

Other major holders of RYTM: RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used